DE69816051D1 - Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien - Google Patents

Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien

Info

Publication number
DE69816051D1
DE69816051D1 DE69816051T DE69816051T DE69816051D1 DE 69816051 D1 DE69816051 D1 DE 69816051D1 DE 69816051 T DE69816051 T DE 69816051T DE 69816051 T DE69816051 T DE 69816051T DE 69816051 D1 DE69816051 D1 DE 69816051D1
Authority
DE
Germany
Prior art keywords
compositions
methods
biological reagent
biological reagents
inhibiting light
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816051T
Other languages
English (en)
Other versions
DE69816051T2 (de
Inventor
F Beuchler
H Mcpherson
R Sundquist
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alere San Diego Inc
Original Assignee
Biosite Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosite Diagnostics Inc filed Critical Biosite Diagnostics Inc
Application granted granted Critical
Publication of DE69816051D1 publication Critical patent/DE69816051D1/de
Publication of DE69816051T2 publication Critical patent/DE69816051T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/13Tracers or tags
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/2525Stabilizing or preserving

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
DE69816051T 1997-04-09 1998-04-06 Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien Expired - Lifetime DE69816051T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US837309 1997-04-09
US08/837,309 US6544797B1 (en) 1997-04-09 1997-04-09 Compositions and methods for inhibiting light-induced inactivation of biological reagents
PCT/US1998/006793 WO1998045705A2 (en) 1997-04-09 1998-04-06 Compositions and methods for inhibiting light-induced inactivation of biological reagents

Publications (2)

Publication Number Publication Date
DE69816051D1 true DE69816051D1 (de) 2003-08-07
DE69816051T2 DE69816051T2 (de) 2004-05-19

Family

ID=25274130

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69816051T Expired - Lifetime DE69816051T2 (de) 1997-04-09 1998-04-06 Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien

Country Status (8)

Country Link
US (2) US6544797B1 (de)
EP (1) EP0972194B1 (de)
JP (1) JP2001519908A (de)
AT (1) ATE244404T1 (de)
AU (1) AU6796598A (de)
CA (1) CA2286183C (de)
DE (1) DE69816051T2 (de)
WO (1) WO1998045705A2 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2799839A1 (fr) * 2000-02-02 2001-04-20 Commissariat Energie Atomique Procede pour determiner la capacite antioxydante de composes chimiques et procedes de dosage et d'immobilisation utilisables pour cette determination
US6800068B1 (en) * 2001-10-26 2004-10-05 Radiant Medical, Inc. Intra-aortic balloon counterpulsation with concurrent hypothermia
US11008359B2 (en) 2002-08-23 2021-05-18 Illumina Cambridge Limited Labelled nucleotides
US20040241880A1 (en) * 2003-05-30 2004-12-02 Leproust Eric M. Ligand array assays having reduced fluorescent dye degradation and compositions for practicing the same
US20040241742A1 (en) * 2003-05-30 2004-12-02 Peck Bill J. Ligand array processing methods that include a low surface tension fluid deposition step and compositions for practicing the same
GB0424294D0 (en) * 2004-11-03 2004-12-01 Elam T Ltd Buffer layer
GB0427236D0 (en) * 2004-12-13 2005-01-12 Solexa Ltd Improved method of nucleotide detection
WO2006064199A1 (en) * 2004-12-13 2006-06-22 Solexa Limited Improved method of nucleotide detection
US7998717B2 (en) * 2005-12-02 2011-08-16 Pacific Biosciences Of California, Inc. Mitigation of photodamage in analytical reactions
US20100311186A1 (en) * 2006-07-28 2010-12-09 Biosite Incorporated Devices and methods for performing receptor binding assays using magnetic particles
US20090043109A1 (en) * 2007-08-07 2009-02-12 Spangler Brenda D Asymmetric one- and two-photon fluorophores for simultaneous detection of multiple analytes using a common excitation source
US20090062386A1 (en) * 2007-08-30 2009-03-05 Clean Earth Technologies, Llc Simulants of Toxants for Training and Testing
US20090057622A1 (en) * 2007-08-31 2009-03-05 Clean Earth Technologies, Llc Simulant of Radiological Contamination
EP2252625B1 (de) * 2008-02-07 2017-12-20 Pacific Biosciences of California, Inc. In linker eingebundene, cis-reaktive sauerstoffquencher
US7968702B2 (en) * 2008-03-13 2011-06-28 Pacific Biosciences Of California, Inc. Labeled reactants and their uses
US8388982B2 (en) * 2008-11-19 2013-03-05 Pacific Biosciences Of California, Inc. Photo-induced damage mitigating agents and preparation and methods of use thereof
DE102009010563A1 (de) 2009-02-16 2010-08-26 Matthias W. Engel Vorrichtung zum Nachweis von Analyten in Körperflüssigkeiten
US9523701B2 (en) 2009-07-29 2016-12-20 Dynex Technologies, Inc. Sample plate systems and methods
GB0913258D0 (en) 2009-07-29 2009-09-02 Dynex Technologies Inc Reagent dispenser
US8834847B2 (en) 2010-08-12 2014-09-16 Pacific Biosciences Of California, Inc. Photodamage mitigation compounds and systems
US8993737B2 (en) 2010-08-25 2015-03-31 Pacific Biosciences, Inc. Phospholinked dye analogs with an amino acid linker
US8486717B2 (en) 2011-01-18 2013-07-16 Symbolics, Llc Lateral flow assays using two dimensional features
US8835000B2 (en) * 2011-12-23 2014-09-16 General Electric Company High-density fluorescent dye clusters
DE102012102082B3 (de) * 2012-03-13 2013-03-21 Thyssenkrupp Rasselstein Gmbh Verfahren zur Behandlung eines mit einer Metallbeschichtung versehenen Stahlbands oder -blechs mit einem Nachbehandlungsmittel sowie ein mit einer Metallbeschichtung versehenes Stahlband oder -blech.
US9315864B2 (en) 2012-05-18 2016-04-19 Pacific Biosciences Of California, Inc. Heteroarylcyanine dyes with sulfonic acid substituents
EP2850086B1 (de) 2012-05-18 2023-07-05 Pacific Biosciences Of California, Inc. Heteroarylcyaninfarbstoffe
US9874556B2 (en) 2012-07-18 2018-01-23 Symbolics, Llc Lateral flow assays using two dimensional features
US20140072959A1 (en) 2012-09-12 2014-03-13 Force Diagnostics, Inc. Rapid tests for insurance underwriting
EP2923204A1 (de) * 2012-10-31 2015-09-30 Astute Medical, Inc. Quantitativer lateralfluss-assay
CA2902484C (en) 2013-02-26 2021-05-18 Astute Medical, Inc. Lateral flow assay with test strip retainer
EP3388442A1 (de) 2013-03-15 2018-10-17 Illumina Cambridge Limited Modifizierte nukleoside oder nukleotide
EP3044592B1 (de) 2013-09-13 2019-07-17 Symbolics, LLC Lateral-flow-tests mit zweidimensionalen test- und steuersignalauslesemustern
JP6286966B2 (ja) * 2013-09-18 2018-03-07 コニカミノルタ株式会社 蛍光標識用樹脂粒子およびその製造方法、並びに、これを含む免疫染色用蛍光標識剤
JP2018513983A (ja) 2015-04-06 2018-05-31 ブルーダイアグノスティックス・インコーポレイテッドBludiagnostics, Inc. 唾液試料中の分析物を検出するための試験装置および使用方法
US11047850B2 (en) * 2017-08-31 2021-06-29 Agilent Technologies, Inc. Composition for stabilization of antibody formulations containing PerCP
US20200363406A1 (en) * 2017-10-26 2020-11-19 The University Of Houston System Highly-specific assays
CN113795595B (zh) 2020-04-20 2023-02-28 深圳华大智造科技股份有限公司 Dna成像缓冲液中的dna保护试剂

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283382A (en) 1977-12-28 1981-08-11 Eastman Kodak Company Fluorescent labels comprising rare earth chelates
US4351760A (en) 1979-09-07 1982-09-28 Syva Company Novel alkyl substituted fluorescent compounds and polyamino acid conjugates
US4420568A (en) 1980-07-30 1983-12-13 Abbott Laboratories Fluorescent polarization immunoassay utilizing substituted triazinylaminofluoresceins
US5075215A (en) 1984-06-11 1991-12-24 Dreyer William J Use of daylight fluorescent pigments for tagging biological molecules
US4868132A (en) 1987-02-03 1989-09-19 Abbott Laboratories Fluorescence polarization immunoassay for amphetamine/methamphetamine
US4876190A (en) 1987-10-21 1989-10-24 Becton Dickinson & Company Peridinin-chlorophyll complex as fluorescent label
DE3919393A1 (de) * 1989-06-14 1990-12-20 Hoechst Ag Verfahren zur stabilisierung von auf festphasen immobilisierten biologisch aktiven substanzen
DE4004296A1 (de) * 1990-02-13 1991-08-14 Hoechst Ag Verbesserte markierte haptene, verfahren zu deren herstellung sowie verwendung dieser markierten haptene in immunoassays
US5747334A (en) * 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5227487A (en) * 1990-04-16 1993-07-13 Molecular Probes, Inc. Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes
EP0529002B1 (de) * 1990-05-15 2001-10-04 Hyperion, Inc. Fluoreszierende porphyrin- und fluoreszierende phthalocyanin-polyethylenglykol-, polyol- und saccharidderivate als fluoreszierende sonden
DE69125992T2 (de) * 1990-09-14 1997-08-21 Tosoh Corp Verfahren und Kit für Immunoassay
JPH06506688A (ja) * 1991-04-10 1994-07-28 バイオサイト・ダイアグノスティックス・インコーポレイテッド クロストークインヒビターおよびその使用
US5230836A (en) * 1991-06-20 1993-07-27 Kalamazoo Holdings, Inc. Low micron-sized ascorbic acid particles, especially a suspension thereof in a medium in which they are insoluble, and the use thereof as an antioxidant for mediums in which the particles remain insoluble
ES2113547T3 (es) * 1992-07-31 1998-05-01 Behringwerke Ag Matrices quimioluminiscentes fotoactivables.
US6238931B1 (en) * 1993-09-24 2001-05-29 Biosite Diagnostics, Inc. Fluorescence energy transfer in particles
US6251687B1 (en) * 1993-09-24 2001-06-26 Biosite Diagnostics, Inc. Fluorescence energy transfer and intramolecular energy transfer in particles using novel compounds
AU4510596A (en) * 1994-12-06 1996-06-26 National Research Council Of Canada Water soluble ubiquinone compositions, prodrugs, and methods relating thereto
US5650512A (en) * 1995-06-07 1997-07-22 Systemix Fluorescent labeling reagents
US5798276A (en) * 1995-06-07 1998-08-25 Molecular Probes, Inc. Reactive derivatives of sulforhodamine 101 with enhanced hydrolytic stability

Also Published As

Publication number Publication date
CA2286183A1 (en) 1998-10-15
WO1998045705A3 (en) 1998-12-30
AU6796598A (en) 1998-10-30
EP0972194B1 (de) 2003-07-02
EP0972194A2 (de) 2000-01-19
DE69816051T2 (de) 2004-05-19
JP2001519908A (ja) 2001-10-23
US20030129642A1 (en) 2003-07-10
WO1998045705A2 (en) 1998-10-15
US6544797B1 (en) 2003-04-08
US7588908B2 (en) 2009-09-15
CA2286183C (en) 2008-11-18
ATE244404T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
DE69816051D1 (de) Zusammensetzungen und verfahren zur hemmung der licht-induzierten inaktivierung von biologischen reagenzien
DE69534300D1 (de) Neues multimerisierendes reagenz
DE69714654D1 (de) Verwendung von einem Metalloporphyrinkonjugat für den Nachweis biologischer Verbindungen
DE69218101D1 (de) Monofluorierte Derivate von N-Propargyl-1-Aminoindan und deren Verwendung als Monoamino-Oxidaseinhibitoren
ATE261310T1 (de) Nicht-antigene von aminen abgeleitete polymere und polymerkonjugate
ATE440963T1 (de) Molekulare fackeln
DE69607830D1 (de) Verfahren zur isothermer amplifikation von nukleinsäure molekülen
BR0016197A (pt) Sistema catalisador múltiplo
ATE373672T1 (de) Synthese von methoxynukleoside und enzymatische nukleisäure moleküle
BR9808491A (pt) Compostos calcilìticos
DK0842934T3 (da) 5-HT1F agonister
DE69819360D1 (de) Neue psoralene zur inaktivierung von pathogenen
ATE208827T1 (de) Konjugate von dns und pns und verfahren zu deren herstellung
ATE495240T1 (de) Ligand des zelleintritt-vermittelnden proteins von herpes simplex virus und methoden zu dessen verwendung
FI925988A (fi) Foerfarande foer framstaellning av b-laktamer
DE69810527D1 (de) 2-(2'-Hydroxphenyl)-benzotriazole und ihre Verwendung als Lichtschutzmittel für organische Polymere
ATE226254T1 (de) Reagenz zur behandlung von arthritischen zustaenden
EP0870058A4 (de) Molekulare sequenze eines retrovirus in schweinen und ihre nutzung
FR2774097B1 (fr) Utilisation de derives d'indolamine dans la detection d'une activite de peptidase ou dans la detection de micro-organismes
ATE240953T1 (de) Carbazolcarboxamide als 5-ht1f agonisten
BR9908799A (pt) Poli (etileno tereftalato) e polìmero de poli (alquileno arilato).
BR9814188A (pt) "agonistas de 5-ht1f"
ATE177069T1 (de) Microbiologischer abbau von alkylenen aminoessigsäuren
FI963055A (fi) Kondensaatio- ja additiopolymeereja, jotka sisältävät N,N'-sillan sisältäviä bis(tetrametyylipiperidinyylioksi)-ryhmiä
IT1291320B1 (it) Procedimento per la preparazione di composti aromatici contenenti un sistema eterociclico

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BIOSITE INCORPORATED, SAN DIEGO, CALIF., US

8364 No opposition during term of opposition